Page last updated: 2024-11-02

palmidrol and Clerambault Syndrome

palmidrol has been researched along with Clerambault Syndrome in 1 studies

palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.

Research Excerpts

ExcerptRelevanceReference
"Inflammation is fundamentally a protective cellular response aimed at removing injurious stimuli and initiating the healing process."2.52N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution. ( Barbierato, M; Bruschetta, G; Cuzzocrea, S; Facci, L; Giusti, P; Impellizzeri, D; Skaper, SD; Zusso, M, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skaper, SD1
Facci, L1
Barbierato, M1
Zusso, M1
Bruschetta, G1
Impellizzeri, D1
Cuzzocrea, S1
Giusti, P1

Reviews

1 review available for palmidrol and Clerambault Syndrome

ArticleYear
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
    Molecular neurobiology, 2015, Volume: 52, Issue:2

    Topics: Administration, Oral; Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Antidepressive Age

2015